Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Siemens Healthineers Demonstrates Power of Data with Atellica Diagnostics IT Solutions

By LabMedica International staff writers
Posted on 05 Aug 2019
Siemens Healthineers (Erlangen, Germany) demonstrated the power of leveraging data to unlock a laboratory’s full potential by showcasing its Atellica Diagnostics IT portfolio at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo. More...
At AACC 2019, the company featured its innovative IT solutions to combat the laboratory’s staffing challenges, limited budgets, and the increasing complexity in sample management and testing.

The Siemens Healthineers Atellica Diagnostics IT portfolio enables laboratories to unlock their full potential by leveraging data to optimize workflows. With easy-to-navigate user interfaces and centralized management of operations, the robust software solution enhances visibility into valuable business analytics that unify sample, process, result, and inventory data. These features have enabled laboratories to achieve a 93% reduction in testing errors, an 85% increase in patient and staff satisfaction, and an 88% achievement rate for 30-minute STAT turnaround.

The Atellica portfolio pipeline includes the Atellica Asa Application, a tablet-based virtual assistant designed to simplify and organize operator interactions with the instruments. The goal of the Atellica Asa Application is to draw staff attention to a single interface with only the most common, yet critical, procedures needed to complete daily system operations. The tile-based software is designed to organize operator tasks by workflow and to reduce the number of screens used to complete a single task.

In addition to demonstrations of the Atellica Asa virtual assistant, attendees learned more about LifeNet, an online program that helps labs increase system utilization by providing a centralized platform to schedule system maintenance and view service history of connected Siemens Healthineers systems. Attendees also explored the artificial intelligence-driven Guardian Program, which can help to predict certain system failures up to 21 days before they happen. By monitoring more than 80 critical components in real time, the Guardian Program can continuously detect potential issues and schedule repairs at a time that will not affect turnaround time, maintaining workflow during peak hours. Visitors to the Siemens Healthineers booth also experienced their own virtual reality journey through a simulated hospital environment to visualize in vitro testing and workflow possibilities based upon tailored needs.

Additionally, Siemens Healthineers unveiled its newest technology for point-of-care testing—the RAPIDPoint 500e Blood Gas System—for product demonstration at the event.

“Point-of-care testing enables clinicians to deliver the right test in the right setting for their patients at the right time,” said Christoph Pedain, PhD, Head of Point-of-Care Diagnostics, Siemens Healthineers.


New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Online QC Software
Acusera 24•7
Prefilled Tubes
Prefilled 5.0ml Tubes
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The approach supports myocardial infarction diagnosis in resource-limited settings by reducing delays between clinical suspicion and biochemical confirmation (Image Credit: Adobe Stock)

Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more

Molecular Diagnostics

view channel
Image: The two new tests are used with the LightCycler 480 and LightCycler PRO instruments (Photo courtesy of Roche)

New PCR Assays Expand Cyclospora Testing for Outbreak Surveillance

Cyclospora cayetanensis, a food- and waterborne intestinal parasite, can cause prolonged diarrhea, fatigue, and abdominal cramping, placing added strain on urgent care and emergency departments during outbreaks.... Read more

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.